83703-543-01 |
83703-543 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Bamboo US Bidco LCC |
CYCLOPHOSPHAMIDE |
500 mg/25mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (83703-543-01) / 25 mL in 1 VIAL, SINGLE-DOSE (83703-543-25) |
83703-547-01 |
83703-547 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Bamboo US Bidco LCC |
CYCLOPHOSPHAMIDE |
2 g/100mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (83703-547-01) / 100 mL in 1 VIAL, SINGLE-DOSE (83703-547-10) |
83703-551-01 |
83703-551 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Bamboo US Bidco LCC |
CYCLOPHOSPHAMIDE |
2 g/100mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (83703-551-01) / 100 mL in 1 VIAL, SINGLE-DOSE (83703-551-10) |
10019-938-01 |
10019-938 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
500 mg/25mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-938-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-938-25) |
10019-944-01 |
10019-944 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
1 g/50mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-944-01) / 50 mL in 1 VIAL, SINGLE-DOSE (10019-944-50) |
68001-442-26 |
68001-442 |
HUMAN PRESCRIPTION DRUG |
Cyclophosphamide |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20201019 |
N/A |
ANDA |
ANDA040745 |
BluePoint Laboratories |
CYCLOPHOSPHAMIDE |
500 mg/25mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (68001-442-26) / 25 mL in 1 VIAL, SINGLE-DOSE |
72572-085-01 |
72572-085 |
HUMAN PRESCRIPTION DRUG |
Cyclophosphamide |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20221214 |
N/A |
ANDA |
ANDA040745 |
Civica, Inc. |
CYCLOPHOSPHAMIDE |
1 g/50mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (72572-085-01) / 50 mL in 1 VIAL, SINGLE-DOSE |
83703-545-01 |
83703-545 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Bamboo US Bidco LCC |
CYCLOPHOSPHAMIDE |
2 g/100mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (83703-545-01) / 100 mL in 1 VIAL, SINGLE-DOSE (83703-545-10) |
83703-549-01 |
83703-549 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Bamboo US Bidco LCC |
CYCLOPHOSPHAMIDE |
500 mg/25mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (83703-549-01) / 25 mL in 1 VIAL, SINGLE-DOSE (83703-549-25) |
10019-936-01 |
10019-936 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
1 g/50mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-936-01) / 50 mL in 1 VIAL, SINGLE-DOSE (10019-936-50) |
10019-942-01 |
10019-942 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
2 g/100mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-942-01) / 100 mL in 1 VIAL, SINGLE-DOSE (10019-942-10) |
10019-956-01 |
10019-956 |
HUMAN PRESCRIPTION DRUG |
Cyclophosphamide |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
1 g/50mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-956-01) / 50 mL in 1 VIAL, SINGLE-DOSE (10019-956-16) |
68001-444-32 |
68001-444 |
HUMAN PRESCRIPTION DRUG |
Cyclophosphamide |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20201019 |
N/A |
ANDA |
ANDA040745 |
BluePoint Laboratories |
CYCLOPHOSPHAMIDE |
2 g/100mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (68001-444-32) / 100 mL in 1 VIAL, SINGLE-DOSE |
83703-544-01 |
83703-544 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Bamboo US Bidco LCC |
CYCLOPHOSPHAMIDE |
1 g/50mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (83703-544-01) / 50 mL in 1 VIAL, SINGLE-DOSE (83703-544-50) |
83703-548-01 |
83703-548 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Bamboo US Bidco LCC |
CYCLOPHOSPHAMIDE |
1 g/50mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (83703-548-01) / 50 mL in 1 VIAL, SINGLE-DOSE (83703-548-50) |
10019-935-01 |
10019-935 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
500 mg/25mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-935-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-935-25) |
10019-939-01 |
10019-939 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
1 g/50mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-939-01) / 50 mL in 1 VIAL, SINGLE-DOSE (10019-939-50) |
10019-945-01 |
10019-945 |
HUMAN PRESCRIPTION DRUG |
CYCLOPHOSPHAMIDE |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
2 g/100mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-945-01) / 100 mL in 1 VIAL, SINGLE-DOSE (10019-945-10) |
10019-955-01 |
10019-955 |
HUMAN PRESCRIPTION DRUG |
Cyclophosphamide |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20080521 |
N/A |
ANDA |
ANDA040745 |
Baxter Healthcare Corporation |
CYCLOPHOSPHAMIDE |
500 mg/25mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (10019-955-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-955-50) |
68001-443-27 |
68001-443 |
HUMAN PRESCRIPTION DRUG |
Cyclophosphamide |
cyclophosphamide |
INJECTION, POWDER, FOR SOLUTION |
INTRAVENOUS; ORAL |
20201019 |
N/A |
ANDA |
ANDA040745 |
BluePoint Laboratories |
CYCLOPHOSPHAMIDE |
1 g/50mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (68001-443-27) / 50 mL in 1 VIAL, SINGLE-DOSE |